Announcements Trials
Browse Landscape

Status

Completed 165Recruiting 33Active not recruiting 33Terminated 30Unknown 18Not yet recruiting 13Withdrawn 12No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 6Glioblastoma 4Recurrence 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Stomach Neoplasms 2Pheochromocytoma 2Ovarian Neoplasms 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Paraganglioma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive 1Meningioma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Medulloblastoma × CNS × Clear all
NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Available
CNS

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡